Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Cara Therapeutics Inc

+ Add to Watchlist

CARA:US

9.8200 USD 0.1000 1.03%

As of 20:10:00 ET on 05/22/2015.

Snapshot for Cara Therapeutics Inc (CARA)

Open: 9.7200 Day's Range: 9.5100 - 9.8600 Volume: 107,588
Previous Close: 9.7200 52wk Range: 7.5300 - 17.7700 1-Yr Rtn: -30.45%

Stock Chart for CARA

No chart data available.
  • CARA:US 9.8200
  • 1D
  • 1M
  • 1Y
9.7200
Interactive CARA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CARA

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.8400
Est. EPS (USD) (12/2015) -1.0790
Est. PEG Ratio -
Market Cap (M USD) 224.14
Shares Outstanding (M) 22.82
30 Day Average Volume 240,082
Price/Book (mrq) 4.7263
Price/Sale (ttm) 63.9586
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/07/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CARA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CARA

Cara Therapeutics, Inc. develops therapeutics. The Company offers novel drugs for the treatment of human diseases associated with pain and inflammation. Cara Therapeutics serves customers in the United States.

Derek ChalmersPresident/CEO/Co-FounderJosef C SchoellChief Financial Officer
Joseph StaufferChief Medical OfficerMichael E LewisChief Scientific Advisor/Secy
More Company Profile & Key Executives for CARA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil